McDonald Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.88M Buy
102,552
+7,726
+8% +$206K 0.68% 46
2025
Q4
$2.36M Buy
94,826
+20,719
+28% +$522K 0.74% 37
2025
Q3
$1.89M Sell
74,107
-42,689
-37% -$1.05M 0.56% 44
2025
Q2
$2.83M Buy
116,796
+1,102
+1% +$25.7K 0.68% 36
2025
Q1
$2.93M Buy
115,694
+5,398
+5% +$141K 0.76% 35
2024
Q4
$2.93M Buy
110,296
+9,963
+10% +$270K 0.75% 37
2024
Q3
$2.9M Buy
100,333
+9,462
+10% +$276K 0.73% 38
2024
Q2
$2.54M Buy
90,871
+23,113
+34% +$636K 0.68% 39
2024
Q1
$1.88M Buy
67,758
+17,939
+36% +$498K 0.52% 54
2023
Q4
$1.43M Sell
49,819
-29,641
-37% -$896K 0.43% 72
2023
Q3
$2.64M Sell
79,460
-6,656
-8% -$235K 0.86% 34
2023
Q2
$3.16M Sell
86,116
-2,192
-2% -$85.3K 0.97% 26
2023
Q1
$3.6M Sell
88,308
-5,926
-6% -$256K 1.17% 16
2022
Q4
$4.83M Sell
94,234
-663
-0.7% -$31.8K 1.65% 11
2022
Q3
$4.15M Sell
94,897
-27,163
-22% -$1.32M 1.58% 13
2022
Q2
$6.4M Sell
122,060
-1,304
-1% -$66.5K 1.63% 7
2022
Q1
$6.39M Buy
123,364
+123,311
+232,662% +$6.4M 1.39% 8
2021
Q4
$3.13K Sell
53
-120,556
-100% -$5.97M ﹤0.01% 286
2021
Q3
$5.19M Sell
120,609
-1,282
-1% -$56.8K 1.22% 15
2021
Q2
$4.77M Buy
121,891
+4,330
+4% +$168K 1.13% 17
2021
Q1
$4.26M Sell
117,561
-1,384
-1% -$49.1K 1.09% 16
2020
Q4
$4.38M Buy
+118,945
New +$4.36M 1.23% 16

Other funds holding PFE

McDonald Partners's PFE Position: Q1 2026 in Review

McDonald Partners increased its Pfizer (PFE) stake by 8.1% in Q1 2026, buying an estimated $206K and bringing the position to 102,552 shares worth $2.88M. The position accounts for 0.68% of the portfolio, ranked #46.

McDonald Partners first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $6.4M in Q2 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • McDonald Partners held 102,552 shares of Pfizer worth $2.88M as of Q1 2026.
  • McDonald Partners bought 7,726 Pfizer shares in Q1 2026, an estimated $206K.
  • Pfizer made up 0.68% of McDonald Partners's portfolio in Q1 2026, its #46 holding.
  • McDonald Partners first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • McDonald Partners's Pfizer position peaked at $6.4M in Q2 2022.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on McDonald Partners's 13F filing for Q1 2026, filed 15 May 2026.